CHS-388

· Coherus Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CHS-388, covering 2025-11-10 to 2025-11-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of CHS-388 (Formerly Known as SRF388) in Patients With Advanced Solid Tumors [Phase 1]